Antidepressant therapy in post-stroke depression

Expert Opinion on Pharmacotherapy

Volumn 9, Issue 8, 2008, Pages 1291-1298

  Starkstein, Sergio E ^a,b   Mizrahi, Romina ^c,d   Power, Brian D ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

^c UNIVERSITY OF TORONTO   (Canada)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Antidepressants; Depression; Psychotheraphy; Stroke

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; DEXAMPHETAMINE; FLUOXETINE; METHYLPHENIDATE; MIANSERIN; NORTRIPTYLINE; PLACEBO; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTICHOLINERGIC EFFECT; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCONVULSIVE THERAPY; EXERCISE; HUMAN; MORTALITY; PATIENT SAFETY; PREVALENCE; PROGNOSIS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SIDE EFFECT; TRANSCRANIAL MAGNETIC STIMULATION; UNSPECIFIED SIDE EFFECT; CONTROLLED CLINICAL TRIAL; STROKE; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CITALOPRAM; CONTROLLED CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER; HUMANS; NORTRIPTYLINE; PROGNOSIS; SERTRALINE; STROKE; TREATMENT OUTCOME;

EID: 45549095014     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.9.8.1291     Document Type: Review

References (59)

1. Robinson RG. The clinical neuropsychiatry of stroke. 2nd edition. Cambridge: Cambridge University Press; 2006
2. Robinson RG. Post-stroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003;54(3):376-87
3. Bolla-Wilson K, Robinson RG, Starkstein SE, et al. Lateralization of dementia of depression in stroke patients. Am J Psychiatry 1989;146(5):627-34
4. Jia H, Damush TM, Qin H, et al. The impact of post-stroke depression on healthcare use by veterans with acute stroke. Stroke 2006;37(11):2796-801
5. Andersen G, Vestergaard K, Ingemann-Nielsen M, Lauritzen L. Risk factors for post-stroke depression. Acta Psychiatr Scand 1995;92(3):193-8
6. Stenager EN, Madsen C, Stenager E, Boldsen J. Suicide in patients with stroke: epidemiological study [see comment]. BMJ 1998;316(7139):1206
7. Wade DT, Legh-Smith J, Hewer RA. Depressed mood after stroke. A community study of its frequency. Br J Psychiatry 1987;151:200-5
8. House A, Knapp P, Bamford J, Vail A. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke 2001;32(3):696-701
9. Morris PL, Robinson RG, Andrezejewski P, et al. Association of depression with 10-year post-stroke mortality. Stroke 1993;150:124-9
10. Robinson RG, Bolduc PL, Price TR. Two-year longitudinal study of post-stroke mood disorders: diagnosis and outcome at one and two years. Stroke 1987;18(5):837-43
11. Mayberg HS, Robinson RG, Wong DF, et al. PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression. Am J Psychiatry 1988;145(8):937-43
12. Starkstein SE, Robinson RG, Price TR. Comparison of patients with and without post-stroke major depression matched for size and location of lesion. Arch Gen Psychiatry 1988;45(3):247-52
13. Narushima K, Kosier JT, Robinson RG. A reappraisal of post-stroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci 2003;15(4):422-30
14. Angeleri F, Angeleri VA, Foschi N, et al. The influence of depression, social activity, and family stress on functional outcome after stroke. Stroke 1993;24(10):1478-83
15. Starkstein SE, Robinson RG. Affective disorders and cerebral vascular disease. Br J Psychiatry 1989;154:170-82
16. Starkstein SE, Robinson RG, Honig MA, et al. Mood changes after right-hemisphere lesions. Br J Psychiatry 1989:155:79-85
17. Morris PL, Raphael B, Robinson RG. Clinical depression is associated with impaired recovery from stroke. Med J Aust 1992;157(4):239-42
18. Hackett ML, Anderson CS. Predictors of depression after stroke: a systematic review of observational studies. Stroke 2005;36(10):2296-301
19. Fedoroff JP, Starkstein SE, Parikh RM, et al. Are depressive symptoms nonspecific in patients with acute stroke? Am J Psychiatry 1991;148(9):1172-6
20. Cicerone KD, Dahlberg C, Kalmar K, et al. Evidence-based cognitive rehabilitation: recommendations for clinical practice. Arch Phys Med Rehabil 2000;81(12):1596-615
21. Robinson RG, Bolla-Wilson K, Kaplan E, et al. Depression influences intellectual impairment in stroke patients. Br J Psychiatry 1986;148:541-7
22. Parikh RM, Robinson RG, Lipsey JR, et al. The impact of post-stroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol 1990;47(7):785-9
23. Gonzalez-Torrecillas JL, Mendlewicz J, Lobo A. Effects of early treatment of post-stroke depression on neuropsychological rehabilitation. Int Psychogeriatr 1995;7(4):547-60
24. Whyte EM, Mulsant BH. Post-stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 2002;52(3):253-64
25. Ebrahim S, Barer D, Nouri F. Affective illness after stroke. Br J Psychiatry 1987;151:52-6
26. House A, Dennis M, Hawton K, Warlow C. Methods of identifying mood disorders in stroke patients: experience in the Oxfordshire Community Stroke Project. Age Ageing 1989;18(6):371-9
27. Eriksson M, Asplund K, Glader EL, et al. Self-reported depression and use of antidepressants after stroke: a national survey. Stroke 2004;35(4):936-41
28. Aylard PR, Gooding JH, McKenna PJ, Snaith RP. A validation study of three anxiety and depression self-assessment scales. J Psychosom Res 1987;31(2):261-8
29. Hackett ML, Anderson CS, House AO. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2004;(3):1-48
30. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960:23:56-62
31. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of post-stroke depression with the selective serotonin reuptake inhibitor citalopram [see comment]. Stroke 1994;25(6):1099-104
32. Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U. Early fluoxetine treatment of post-stroke depression - a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol 2003;250(3):347-51
33. Lipsey JR, Robinson RG, Pearlson GD, et al. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984;1(8372):297-300
34. Murray V, von Arbin M, Bartfai A, et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry 2005;66(6):708-16
35. Ohtomo E, Hirai S, Terashi A, et al. Clinical evaluation of aniracetam on psychiatric symptoms related to cerebrovascular disease. J Clin Exp Med 1991;156:143-87
36. Reding MJ, Orto LA, Winter SW, et al. Antidepressant therapy after stroke. A double-blind trial. Arch Neurol 1986;43(8):763-5
37. Wiart L, Petit H, Joseph PA, et al. Fluoxetine in early post-stroke depression: a double-blind placebo-controlled study. Stroke 2000;31(8):1829-32
38. Chen Y, Guo JJ, Zhan S, Patel NC. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis. Ann Pharmacother 2006;40(12):2115-22
39. Masand P, Murray GB, Pickett P. Psychostimulants in post-stroke depression. J Neuropsychiatry Clin Neurosci 1991;3(1):23-7
40. Lazarus LW, Moberg PJ, Langsley PR, Lingam VR. Methylphenidate and nortriptyline in the treatment of post-stroke depression: a retrospective comparison. Arch Phys Med Rehabil 1994;75(4):403-6
41. Williams LS, Kroenke K, Bakas T, et al. Care management of post-stroke depression: a randomized, controlled trial. Stroke 2007;38(3):998-1003
42. Lai SM, Studenski S, Richards L, et al. Therapeutic exercise and depressive symptoms after stroke. J Am Geriatr Soc 2006;54(2):240-7
43. Rachid F, Bertschy G. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of depression: a critical appraisal of the last 10 years. Neurophysiol Clin 2006;36:157-83
44. Jorge RE, Robinson RG, Tateno A, et al. Repetitive transcranial magnetic stimulation as treatment of post-stroke depression: a preliminary study. Biol Psychiatry 2004;55(4):398-405
45. Murray GB, Shea V, Conn DK. Electroconvulsive therapy for post-stroke depression. J Clin Psychiatry 1986;47(5):258-60
46. Currier MB, Murray GB, Welch CC. Electroconvulsive therapy for post-stroke depressed geriatric patients. J Neuropsychiatry Clin Neurosci 1992;4(2):140-4
47. Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortality and post-stroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003;160(10):1823-9
48. Palomaki H, Kaste M, Berg A, et al. Prevention of post-stroke depression: 1-year randomised placebo controlled double-blind trial of mianserin with 6-month follow-up after therapy. J Neurol Neurosurg Psychiatry 1999;66(4):490-4
49. Narushima K, Kosier JT, Robinson RG. Preventing post-stroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis 2002;190(5):296-303
50. Rasmussen A, Lunde M, Poulsen DL, et al. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003;44(3):216-21
51. Almeida OP, Waterreus A, Hankey GJ. Preventing depression after stroke: Results from a randomized placebo-controlled trial. J Clin Psychiatry 2006;67(7):1104-9
52. Anderson CS, Hackett ML, House A. Interventions for preventing depression after stroke. Cochrane Database Syst Rev 2004;(2):1-55
53. Duman RS. Depression: a case of neuronal life and death? Biol Psychiatry 2004;56(3):140-5
54. Sapolsky RM. Is impaired neurogenesis relevant to the affective symptoms of depression? Biol Psychiatry 2004;56(3):137-9
55. Schmidt HD, Duman RS. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 2007;18(5-6):391-418
56. Banasr M, Duman RS. Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol Disord Drug Targets 2007;6(5):311-20
57. Perera TD, Coplan JD, Lisanby SH, et al. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci 2007;27(18):4894-901
58. Sahay A, Hen R. Adult hippocampal neurogenesis in depression. Nat Neurosci 2007;10(9):1110-5
59. Malberg JE. Implications of adult hippocampal neurogenesis in antidepressant action. J Psychiatry Neurosci 2004;29(3):196-205